SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome
NCT07214818
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Nephrotic Syndrome
Interventions
DRUG:
Dapagliflozin
DRUG:
Empagliflozin
OTHER:
Standard Therapy
Sponsor
Mansoura University